Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II

HOME

HELP

FEEDBACK

SUBSCRIPTIONS

Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II

GL Hortin, DM Tollefsen and BM Benutto
Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.

Heparin cofactor II (HCII) is a highly specific serine proteinase inhibitor, which complexes covalently with thrombin in a reaction catalyzed by heparin and other polyanions. The molecular basis for the thrombin specificity may be explained by the identification here of a segment of HCII including residues 54-75 that binds to thrombin. A synthetic peptide, HCII(54-75), based on this segment of HCII, Gly-Glu- Glu-Asp-Asp-Asp-Tyr-Leu-Asp-Leu-Glu- Lys-Ile-Phe-Ala-Glu-Asp-Asp-Asp- Tyr-Ile-Asp inhibited thrombin's cleavage of fibrinogen. Clotting activity of thrombin was inhibited 50% at a concentration of 28 microM. Polyacrylamide gel electrophoresis showed that HCII(54-75) inhibited thrombin's cleavage of both the A alpha and B beta polypeptides in fibrinogen. However, the peptide did not block thrombin's active site, as hydrolysis of chromogenic substrates was not inhibited. HCII(54-75) probably binds to the same site on thrombin as do carboxyl-terminal residues of hirudins, thrombin inhibitors of leeches. HCII(54-75) inhibited binding of thrombin to a synthetic peptide corresponding to residues 54-66 of hirudin PA, but the hirudin peptide was about 30-fold more potent in binding and clotting assays. Both synthetic peptides, as a result of their polyanionic character, might be expected to stimulate the reaction of HCII with thrombin. However, the hirudin-related peptide inhibited this reaction, suggesting that it blocked a site on thrombin required for interaction with HCII. HCII(54-75) had a net stimulatory effect on the thrombin-HCII reaction as a consequence of its lower affinity for thrombin and greater negative charge relative to the hirudin-related peptide. These studies suggest that residues 54-75 of HCII interact with a noncatalytic binding site on thrombin and that this interaction contributes to efficient inhibition of thrombin by HCII.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

D. M. Tollefsen
Heparin Cofactor II Modulates the Response to Vascular Injury
Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 454 - 460.
[Abstract] [Full Text] [PDF]

V. H. Pomin, M. S. Pereira, A.-P. Valente, D. M. Tollefsen, M. S. G. Pavao, and P. A. S. Mourao
Selective cleavage and anticoagulant activity of a sulfated fucan: stereospecific removal of a 2-sulfate ester from the polysaccharide by mild acid hydrolysis, preparation of oligosaccharides, and heparin cofactor II-dependent anticoagulant activity
Glycobiology, April 1, 2005; 15(4): 369 - 381.
[Abstract] [Full Text] [PDF]

I. M. Verhamme, P. E. Bock, and C. M. Jackson
The Preferred Pathway of Glycosaminoglycan-accelerated Inactivation of Thrombin by Heparin Cofactor II
J. Biol. Chem., March 12, 2004; 279(11): 9785 - 9795.
[Abstract] [Full Text] [PDF]

D. O. Beck, M. A. Bukys, L. S. Singh, K. A. Szabo, and M. Kalafatis
The Contribution of Amino Acid Region Asp695-Tyr698 of Factor V to Procofactor Activation and Factor Va Function
J. Biol. Chem., January 23, 2004; 279(4): 3084 - 3095.
[Abstract] [Full Text] [PDF]

M. Kalafatis, D. O. Beck, and K. G. Mann
Structural Requirements for Expression of Factor Va Activity
J. Biol. Chem., August 29, 2003; 278(35): 33550 - 33561.
[Abstract] [Full Text] [PDF]

C. H. Pospisil, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz
Evidence That Both Exosites on Thrombin Participate in Its High Affinity Interaction with Fibrin
J. Biol. Chem., June 6, 2003; 278(24): 21584 - 21591.
[Abstract] [Full Text] [PDF]

J. W. Mitchell and F. C. Church
Aspartic Acid Residues 72 and 75 and Tyrosine-sulfate 73 of Heparin Cofactor II Promote Intramolecular Interactions during Glycosaminoglycan Binding and Thrombin Inhibition
J. Biol. Chem., May 24, 2002; 277(22): 19823 - 19830.
[Abstract] [Full Text] [PDF]

P. C. Y. Liaw, R. C. Austin, J. C. Fredenburgh, A. R. Stafford, and J. I. Weitz
Comparison of Heparin- and Dermatan Sulfate-mediated Catalysis of Thrombin Inactivation by Heparin Cofactor II
J. Biol. Chem., September 24, 1999; 274(39): 27597 - 27604.
[Abstract] [Full Text] [PDF]

T. Myles, F. C. Church, H. C. Whinna, D. Monard, and S. R. Stone
Role of Thrombin Anion-binding Exosite-I in the Formation of Thrombin-Serpin Complexes
J. Biol. Chem., November 20, 1998; 273(47): 31203 - 31208.
[Abstract] [Full Text] [PDF]

J.-H. Han, H. C.�F. Cote, and D. M. Tollefsen
Inhibition of Meizothrombin and Meizothrombin(desF1) by Heparin Cofactor II
J. Biol. Chem., November 7, 1997; 272(45): 28660 - 28665.
[Abstract] [Full Text] [PDF]

P. M. Sherman, D. A. Lawrence, I. M. Verhamme, D. Paielli, J. D. Shore, and D. Ginsburg
Identification of Tissue-type Plasminogen Activator-specific Plasminogen Activator Inhibitor-1 Mutants
J. Biol. Chem., April 21, 1995; 270(16): 9301 - 9306.
[Abstract] [Full Text] [PDF]

D. D. Callas, O. Iqbal, D. Hoppensteadt, and J. Fareed
Fibrinolytic Compromise by Synthetic and Recombinant Thrombin Inhibitors: Implications in the Treatment of Thrombotic Disorders
Clinical and Applied Thrombosis/Hemostasis, March 1, 1995; 1(2): 114 - 124.
[Abstract] [PDF]

P. J. Anderson, A. Nesset, K. R. Dharmawardana, and P. E. Bock
Characterization of Proexosite I on Prothrombin
J. Biol. Chem., May 26, 2000; 275(22): 16428 - 16434.
[Abstract] [Full Text] [PDF]

P. C. Y. Liaw, D. L. Becker, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz
Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin
J. Biol. Chem., June 8, 2001; 276(24): 20959 - 20965.
[Abstract] [Full Text] [PDF]